138 related articles for article (PubMed ID: 11448945)
1. Steroid hormone receptor-mediated histone deacetylation and transcription at the mouse mammary tumor virus promoter.
Sheldon LA; Becker M; Smith CL
J Biol Chem; 2001 Aug; 276(35):32423-6. PubMed ID: 11448945
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
Mulholland NM; Soeth E; Smith CL
Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.
List HJ; Smith CL; Rodriguez O; Danielsen M; Riegel AT
Exp Cell Res; 1999 Nov; 252(2):471-8. PubMed ID: 10527637
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure.
Astrand C; Klenka T; Wrange O; Belikov S
Eur J Biochem; 2004 Mar; 271(6):1153-62. PubMed ID: 15009194
[TBL] [Abstract][Full Text] [Related]
5. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure.
Bartsch J; Truss M; Bode J; Beato M
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10741-6. PubMed ID: 8855250
[TBL] [Abstract][Full Text] [Related]
6. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
Aoyagi S; Archer TK
Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
[TBL] [Abstract][Full Text] [Related]
7. CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins.
Lambert JR; Nordeen SK
Mol Endocrinol; 2003 Jun; 17(6):1085-94. PubMed ID: 12637584
[TBL] [Abstract][Full Text] [Related]
8. Steroid-selective initiation of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter is controlled by the site of promoter integration.
Lambert JR; Nordeen SK
J Biol Chem; 1998 Dec; 273(49):32708-14. PubMed ID: 9830013
[TBL] [Abstract][Full Text] [Related]
9. Osmotic stress-dependent repression is mediated by histone H3 phosphorylation and chromatin structure.
Burkhart BA; Kennett SB; Archer TK
J Biol Chem; 2007 Feb; 282(7):4400-4407. PubMed ID: 17158874
[TBL] [Abstract][Full Text] [Related]
10. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter.
Lee HL; Archer TK
EMBO J; 1998 Mar; 17(5):1454-66. PubMed ID: 9482742
[TBL] [Abstract][Full Text] [Related]
11. Complex role of histone H1 in transactivation of MMTV promoter chromatin by progesterone receptor.
Vicent GP; Koop R; Beato M
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):15-23. PubMed ID: 12650697
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.
Archer TK; Fryer CJ; Lee HL; Zaniewski E; Liang T; Mymryk JS
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):421-9. PubMed ID: 7626491
[TBL] [Abstract][Full Text] [Related]
13. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus.
Ham J; Thomson A; Needham M; Webb P; Parker M
Nucleic Acids Res; 1988 Jun; 16(12):5263-76. PubMed ID: 2838812
[TBL] [Abstract][Full Text] [Related]
14. The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.
Archer TK; Zaniewski E; Moyer ML; Nordeen SK
Mol Endocrinol; 1994 Sep; 8(9):1154-62. PubMed ID: 7838148
[TBL] [Abstract][Full Text] [Related]
15. The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor.
Kinyamu HK; Fryer CJ; Horwitz KB; Archer TK
J Biol Chem; 2000 Jun; 275(26):20061-8. PubMed ID: 10751396
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional silencing of the mouse mammary tumor virus promoter through chromatin remodeling is concomitant with histone H1 phosphorylation and histone H3 hyperphosphorylation at M phase.
Bhattacharjee RN; Archer TK
Virology; 2006 Mar; 346(1):1-6. PubMed ID: 16458342
[TBL] [Abstract][Full Text] [Related]
17. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Mymryk JS; Archer TK
Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
[TBL] [Abstract][Full Text] [Related]
18. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter.
Archer TK; Lee HL; Cordingley MG; Mymryk JS; Fragoso G; Berard DS; Hager GL
Mol Endocrinol; 1994 May; 8(5):568-76. PubMed ID: 8058066
[TBL] [Abstract][Full Text] [Related]
19. Erk signaling and chromatin remodeling in MMTV promoter activation by progestins.
Vicent GP; Zaurin R; Ballaré C; Nacht AS; Beato M
Nucl Recept Signal; 2009 Oct; 7():e008. PubMed ID: 20087429
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the hormone regulatory element of mouse mammary tumor virus differentially affect the response to progestins, androgens, and glucocorticoids.
Gowland PL; Buetti E
Mol Cell Biol; 1989 Sep; 9(9):3999-4008. PubMed ID: 2550809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
